PKUMDL-CLM-32

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NamePKUMDL-CLM-32
Drug Alias NamePKUMDL-CLM-32
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPeking University
China Registration ClassN/A

Develop Information

Active CompaniesPeking University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A